Home / Resource Library / SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma

SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma

Results of a study investigating ibrutinib with rituximab for treatment of follicular lymphoma.